Literature DB >> 27136408

Predictors of Fatigue Impact in Persons With Long-Standing Multiple Sclerosis.

Janet D Morrison1, Alexa K Stuifbergen.   

Abstract

BACKGROUND: Fatigue is a common experience among persons diagnosed with multiple sclerosis (MS). Fatigue negatively influences quality of life, interferes with activities of daily living, and impairs the ability to maintain gainful employment. Mechanisms underlying the pathophysiologic determinants of fatigue in MS are poorly understood, and effective treatments to manage fatigue present a challenge. Although the use of pharmacologic therapies is recommended to treat symptomatic fatigue, undertreatment of fatigue is common. Better long-term management and symptomatic relief may be provided by the use of nonpharmacologic treatments such as increased physical activity, energy conservation, and cognitive behavioral therapy.
METHODS: The purpose of this study was to explore the physical, cognitive, and psychosocial dimensions of fatigue impact among persons with long-standing MS-defined here as having been diagnosed with MS for 17 years or more. A sample of 331 participants with MS completed surveys measuring fatigue impact, MS-related functional limitation, depressive symptoms, barriers to health promotion, personal resources, and health promoting behaviors.
RESULTS: MS-related functional limitation and depressive symptoms were the strongest predictors of fatigue impact. MS-related functional limitation explained the greatest amount of variance in models predicting physical and psychosocial fatigue impact, whereas depressive symptoms explained the most variance in models predicting total and cognitive fatigue impact. Barriers to health promotion explained the least amount of variance among the models. Personal resources and health promoting behaviors were not significant predictors of fatigue impact in this study.
CONCLUSION: Interventions aimed at reducing MS-related functional limitations, depressive symptoms, and barriers to health promotion may have beneficial influences on fatigue impact, whereas actions designed to promote personal resource adequacy as well as engagement in health promoting behaviors may not translate into improvements in fatigue impact in persons with MS.

Entities:  

Mesh:

Year:  2016        PMID: 27136408      PMCID: PMC4853822          DOI: 10.1097/JNN.0000000000000208

Source DB:  PubMed          Journal:  J Neurosci Nurs        ISSN: 0888-0395            Impact factor:   1.230


  35 in total

1.  Fatigue and declines in cognitive functioning in multiple sclerosis.

Authors:  L B Krupp; L E Elkins
Journal:  Neurology       Date:  2000-10-10       Impact factor: 9.910

Review 2.  Fatigue in multiple sclerosis: definition, pathophysiology and treatment.

Authors:  Lauren B Krupp
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

3.  Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters.

Authors:  P Flachenecker; T Kümpfel; B Kallmann; M Gottschalk; O Grauer; P Rieckmann; C Trenkwalder; K V Toyka
Journal:  Mult Scler       Date:  2002-12       Impact factor: 6.312

4.  What makes it so hard? Barriers to health promotion experienced by people with multiple sclerosis and polio.

Authors:  Heather Becker; Alexa Stuifbergen
Journal:  Fam Community Health       Date:  2004 Jan-Mar

5.  The effects of a group-based cognitive behavioral therapy on people with multiple sclerosis: a randomized controlled trial.

Authors:  Federica Graziano; Emanuela Calandri; Martina Borghi; Silvia Bonino
Journal:  Clin Rehabil       Date:  2013-09-06       Impact factor: 3.477

6.  The Health-Promoting Lifestyle Profile: development and psychometric characteristics.

Authors:  S N Walker; K R Sechrist; N J Pender
Journal:  Nurs Res       Date:  1987 Mar-Apr       Impact factor: 2.381

7.  Quality of life in multiple sclerosis: the impact of depression, fatigue and disability.

Authors:  M P Amato; G Ponziani; F Rossi; C L Liedl; C Stefanile; L Rossi
Journal:  Mult Scler       Date:  2001-10       Impact factor: 6.312

Review 8.  Fatigue in multiple sclerosis.

Authors:  L B Krupp; C Christodoulou
Journal:  Curr Neurol Neurosci Rep       Date:  2001-05       Impact factor: 5.081

9.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

10.  Symptomatic medication use in multiple sclerosis.

Authors:  G Brichetto; M Messmer Uccelli; G L Mancardi; C Solaro
Journal:  Mult Scler       Date:  2003-10       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.